These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4003635)

  • 21. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers.
    Hellberg D; Nilsson S; Haley NJ; Hoffman D; Wynder E
    Am J Obstet Gynecol; 1988 Apr; 158(4):910-3. PubMed ID: 3364502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative sensitivity and specificity of salivary and serum cotinine in identifying tobacco-smoking status of self-reported nonsmokers and smokers of tobacco and/or marijuana.
    van Vunakis H; Tashkin DP; Rigas B; Simmons M; Gjika HB; Clark VA
    Arch Environ Health; 1989; 44(1):53-8. PubMed ID: 2644896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive exposure to tobacco smoke: saliva cotinine concentrations in a representative population sample of non-smoking schoolchildren.
    Jarvis MJ; Russell MA; Feyerabend C; Eiser JR; Morgan M; Gammage P; Gray EM
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):927-9. PubMed ID: 3929967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biochemical markers of smoke absorption and self reported exposure to passive smoking.
    Jarvis M; Tunstall-Pedoe H; Feyerabend C; Vesey C; Salloojee Y
    J Epidemiol Community Health; 1984 Dec; 38(4):335-9. PubMed ID: 6512488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cotinine determination by immunoassays may be influenced by other nicotine metabolites.
    Schepers G; Walk RA
    Arch Toxicol; 1988; 62(5):395-7. PubMed ID: 3242451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measuring problems in estimating the exposure to passive smoking using the excretion of cotinine.
    Letzel H; Fischer-Brandies A; Johnson LC; Uberla K; Biber A
    Toxicol Lett; 1987 Jan; 35(1):35-44. PubMed ID: 3810680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High performance liquid chromatographic determination of nicotine and cotinine in plasma and nicotine and cotinine, simultaneously, in urine.
    Sioufi A; Parisot C; Sandrenan N; Dubois JP
    Methods Find Exp Clin Pharmacol; 1989 Mar; 11(3):179-85. PubMed ID: 2725116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cotinine validation of self-reported smoking in commercially run community surveys.
    Pierce JP; Dwyer T; DiGiusto E; Carpenter T; Hannam C; Amin A; Yong C; Sarfaty G; Shaw J; Burke N
    J Chronic Dis; 1987; 40(7):689-95. PubMed ID: 3597671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some properties of saliva cotinine measurements in indicating exposure to tobacco smoking.
    Di Giusto E; Eckhard I
    Am J Public Health; 1986 Oct; 76(10):1245-6. PubMed ID: 3752331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay for nicotine and cotinine.
    Van Vunakis H; Gjika HB; Langone JJ
    IARC Sci Publ; 1987; (81):317-30. PubMed ID: 3323053
    [No Abstract]   [Full Text] [Related]  

  • 31. A comparison of nicotine dose estimates in smokers between filter analysis, salivary cotinine, and urinary excretion of nicotine metabolites.
    St Charles FK; Krautter GR; Dixon M; Mariner DC
    Psychopharmacology (Berl); 2006 Dec; 189(3):345-54. PubMed ID: 17028908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variability of measures of exposure to environmental tobacco smoke in the home.
    Coultas DB; Samet JM; McCarthy JF; Spengler JD
    Am Rev Respir Dis; 1990 Sep; 142(3):602-6. PubMed ID: 2389911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of biochemical validation measures in determination of smoking status.
    Stookey GK; Katz BP; Olson BL; Drook CA; Cohen SJ
    J Dent Res; 1987 Oct; 66(10):1597-601. PubMed ID: 3305621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiocyanate vs cotinine as a marker to identify smokers.
    Steinman GD
    Clin Chem; 1985 Aug; 31(8):1406. PubMed ID: 4017248
    [No Abstract]   [Full Text] [Related]  

  • 35. Cotinine levels in follicular fluid and serum of IVF patients: effect on granulosa-luteal cell function in vitro.
    Weiss T; Eckert A
    Hum Reprod; 1989 Jul; 4(5):482-5. PubMed ID: 2794009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of monoclonal and polyclonal antibodies to cotinine in nonisotopic and isotopic immunoassays.
    Bjercke RJ; Cook G; Langone JJ
    J Immunol Methods; 1987 Feb; 96(2):239-46. PubMed ID: 3543136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey.
    Jarvis MJ; Boreham R; Primatesta P; Feyerabend C; Bryant A
    J Natl Cancer Inst; 2001 Jan; 93(2):134-8. PubMed ID: 11208883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of biochemical intake markers to passive smoking measurement and risk estimation.
    Jarvis MJ
    Mutat Res; 1989 Feb; 222(2):101-10. PubMed ID: 2645516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An automated colorimetric assay for urine nicotine metabolites: a suitable alternative to cotinine assays for the assessment of smoking status.
    Puhakainen EV; Barlow RD; Salonen JT
    Clin Chim Acta; 1987 Dec; 170(2-3):255-62. PubMed ID: 3436059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mathematical modeling of nicotine and cotinine as biological markers of environmental tobacco smoke exposure.
    Schwartz SL; Ball RT; Witorsch P
    Toxicol Lett; 1987 Jan; 35(1):53-8. PubMed ID: 3810682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.